generic sterile injectable market

Global Generic Sterile Injectable Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027

  • Published Date: 2021-03-24
  • Report ID: 77769
  • Pages: 113
  • Format: prudent report format

Summary

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales.Prudent Markets published a report for global Generic Sterile Injectable market in this environment.

In terms of revenue, this research report indicated that the global Generic Sterile Injectable market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Generic Sterile Injectable industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The Baxter aims at producing XX K Units Generic Sterile Injectable in 2020, with XX % production to take place in global market, Fresenius Kabi accounts for a volume share of XX %.

Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Generic Sterile Injectable Market byPrudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Generic Sterile Injectable Market
Baxter
Fresenius Kabi
Pfizer/Hospira
Novartis/Sandoz
Teva
Hikma
Sun Pharma
Dr. Reddys
Mylan
AstraZeneca Plc
Merck & Co.
...
Major Type of Generic Sterile Injectable Covered inPrudent Markets report:
Monoclonal Antibodies
Cytokines
Insulin
Peptide Hormones
Vaccines
Application Segments Covered inPrudent Markets Market
Hospitals
Drug Stores
Pharmacies
Online Pharmacies

For any other requirements, please feel free to contact us and we will provide you customized report.


Table of Contents

Global Generic Sterile Injectable Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Monoclonal Antibodies -Product Introduction and Major Manufacturers
1.1.2 Cytokines -Product Introduction and Major Manufacturers
1.1.3 Insulin -Product Introduction and Major Manufacturers
1.1.4 Peptide Hormones -Product Introduction and Major Manufacturers
1.1.5 Vaccines -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Generic Sterile Injectable Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Generic Sterile Injectable Market
3.1.1 Top Companies leading Generic Sterile Injectable Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Generic Sterile Injectable Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Generic Sterile Injectable Market
3.2.1 Top Companies leading Generic Sterile Injectable Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Generic Sterile Injectable Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Generic Sterile Injectable Market
3.3.1 Top Companies leading Generic Sterile Injectable Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Generic Sterile Injectable Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Generic Sterile Injectable Market
3.4.1 Top Companies leading Generic Sterile Injectable Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Generic Sterile Injectable Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Generic Sterile Injectable Market
3.5.1 Top Companies leading Generic Sterile Injectable Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Generic Sterile Injectable Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Generic Sterile Injectable Market
3.6.1 Top Companies leading Generic Sterile Injectable Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Generic Sterile Injectable Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Generic Sterile Injectable Market
3.7.1 Top Companies leading Generic Sterile Injectable Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Generic Sterile Injectable Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Generic Sterile Injectable Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Generic Sterile Injectable Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Generic Sterile Injectable Sales and Growth Rate (2021-2027)
5.2 Global Generic Sterile Injectable Sales Value and Growth Rate (2021-2027)

6 Generic Sterile Injectable Competitive Analysis
6.1 Baxter
6.1.1 Baxter Company Profiles
6.1.2 Baxter Product Introduction
6.1.3 Baxter Generic Sterile Injectable Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Fresenius Kabi
6.2.1 Fresenius Kabi Company Profiles
6.2.2 Fresenius Kabi Product Introduction
6.2.3 Fresenius Kabi Generic Sterile Injectable Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Pfizer/Hospira
6.3.1 Pfizer/Hospira Company Profiles
6.3.2 Pfizer/Hospira Product Introduction
6.3.3 Pfizer/Hospira Generic Sterile Injectable Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Novartis/Sandoz
6.4.1 Novartis/Sandoz Company Profiles
6.4.2 Novartis/Sandoz Product Introduction
6.4.3 Novartis/Sandoz Generic Sterile Injectable Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Teva
6.5.1 Teva Company Profiles
6.5.2 Teva Product Introduction
6.5.3 Teva Generic Sterile Injectable Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Hikma
6.6.1 Hikma Company Profiles
6.6.2 Hikma Product Introduction
6.6.3 Hikma Generic Sterile Injectable Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Sun Pharma
6.7.1 Sun Pharma Company Profiles
6.7.2 Sun Pharma Product Introduction
6.7.3 Sun Pharma Generic Sterile Injectable Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Dr. Reddys
6.8.1 Dr. Reddys Company Profiles
6.8.2 Dr. Reddys Product Introduction
6.8.3 Dr. Reddys Generic Sterile Injectable Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Mylan
6.9.1 Mylan Company Profiles
6.9.2 Mylan Product Introduction
6.9.3 Mylan Generic Sterile Injectable Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 AstraZeneca Plc
6.10.1 AstraZeneca Plc Company Profiles
6.10.2 AstraZeneca Plc Product Introduction
6.10.3 AstraZeneca Plc Generic Sterile Injectable Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Merck & Co.
7 Conclusion


CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.